Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Epidural Anesthetic Drugs and Device Market by Type (Epidural Anesthetic Drugs, Epidural Anesthetic Device), By Application (Abdomen Procedures, Pelvic Procedures, Lower Extremity Procedures, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Epidural Anesthetic Drugs and Device Market by Type (Epidural Anesthetic Drugs, Epidural Anesthetic Device), By Application (Abdomen Procedures, Pelvic Procedures, Lower Extremity Procedures, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 241449 4200 Medical Care 377 218 Pages 4.9 (45)
                                          

Market Overview:


The global epidural anesthetic drugs and device market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing number of surgeries, rising geriatric population, and technological advancements in the field of epidural anesthesia. Based on type, the global epidural anesthetic drugs and device market is segmented into epidural anesthetic drugs and epidural anesthetic devices. Epidural anesthetic drugs are further sub-segmented into local anaesthetics (lidocaine, bupivacaine) and general anaesthetics (propofol). Epidural anaesthesia devices are further classified into single-use devices and reusable devices. Based on application, the global epidual analgesia market is segmented into abdomen procedures, pelvic procedures, lower extremity procedures, and others. Geographically, the global epidual analgesia market is segmented into North America,, Latin America,, Europe,, Asia Pacific,,and Middle East & Africa,. The North American region dominates the global epdurla analgesia market due to factors such as high prevalence of chronic pain conditions; growing geriatric population; increasing number of surgeries; favourable reimbursement scenario for medical treatments; presence of key players in this region;and technological advancements in this field.


Global Epidural Anesthetic Drugs and Device Industry Outlook


Product Definition:


Epidural anesthetic drugs and devices are used to numb the lower half of the body for surgery or childbirth. They can be given through a needle in the back or delivered through a catheter threaded into the epidural space between the spinal cord and bone. Epidural anesthesia numbs the nerves that carry pain signals from below your waist, making surgery less painful and childbirth easier.


Epidural Anesthetic Drugs:


Epidural Anesthetic Drugs are used for pain management during childbirth. They work by decreasing the ability of pain nerves to transmit signals to the brain, thereby creating an epidural zone of anesthesia around the spinal cord and nerve roots that blocks allodynia (pain) and hyperalgesia (feelings of pain). Epidural Anesthetics are also known as Spinal Anaesthesia or Central Nervous System Anaesthesia.


Epidural Anesthetic Device:


Epidural anesthetic device is used for providing anesthesia during childbirth. Epidural anesthetics are also known as spinal or nerve block. These drugs are used in combination with other drugs to perform a surgical procedure on the spine of patient, which ultimately reduces pain by blocking the nerves that go to the area of concern.


Application Insights:


The abdomen procedures segment dominated the global epidural anesthetic drugs and device market in 2017. This can be attributed to factors such as increasing number of abdominal surgeries, growing geriatric population, and rising awareness about pain management. For instance, according to the American Society of Plastic Surgeons (ASPS), in 2018 nearly 1 out of 5 U.S citizens aged 18-64 years had some form of cosmetic surgery performed on them during that year. Furthermore, ASPS also reported that nearly 3 out 4 minimally invasive cosmetic procedures are being done on adults compared to only 2/3rds for those aged 55+ years undergoing minimally invasive surgeries.


The pelvic procedures segment is expected register significant growth rate during the forecast period owing to increasing number by volume.


Regional Analysis:


North America dominated the global market in 2017 owing to the presence of well-established healthcare facilities and a large number of product launches. The region is expected to maintain its dominance during the forecast period due to increasing per capita income, high level of awareness about spinal anesthesia, and availability of highly skilled doctors. Moreover, an increase in government initiatives for quality improvement is also expected to drive regional growth over the forecast period.


Asia Pacific is anticipated to be one of fastest growing regions during the same period owing rising medical tourism especially from developing countries such as India & China & Australia. Increase in demand for minimally invasive surgeries coupled with rapidly improving healthcare infrastructure will drive this regional market over next eight years. In addition, favorable government policies are also likely boost growth by providing tax benefits and other financial incentives for manufacturers/centers/universities etc., that develop innovative products or improve existing ones’ safety & efficacy in low dose epidurals compared with traditional methods (i.


Growth Factors:


  • Increasing demand for pain relief medications and devices
  • Rising incidence of chronic pain conditions
  • Growing geriatric population susceptible to chronic pain conditions
  • Technological advancements in epidural anesthetic drugs and devices
  • increasing healthcare expenditure

Scope Of The Report

Report Attributes

Report Details

Report Title

Epidural Anesthetic Drugs and Device Market Research Report

By Type

Epidural Anesthetic Drugs, Epidural Anesthetic Device

By Application

Abdomen Procedures, Pelvic Procedures, Lower Extremity Procedures, Others

By Companies

Taj Pharmaceuticals Ltd, Pfizer, Fresenius Kabi, Areva Pharmaceuticals Inc., Farco Pharma GmbH, Mahendra Chemicals, Aurobindo Pharma Ltd, Amphastar Pharmaceuticals, Inc., B.Braun, BD, Meditech Devices, Smith Medical, Teleflex

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

218

Number of Tables & Figures

153

Customization Available

Yes, the report can be customized as per your need.


Global Epidural Anesthetic Drugs and Device Market Report Segments:

The global Epidural Anesthetic Drugs and Device market is segmented on the basis of:

Types

Epidural Anesthetic Drugs, Epidural Anesthetic Device

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Abdomen Procedures, Pelvic Procedures, Lower Extremity Procedures, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Taj Pharmaceuticals Ltd
  2. Pfizer
  3. Fresenius Kabi
  4. Areva Pharmaceuticals Inc.
  5. Farco Pharma GmbH
  6. Mahendra Chemicals
  7. Aurobindo Pharma Ltd
  8. Amphastar Pharmaceuticals, Inc.
  9. B.Braun
  10. BD
  11. Meditech Devices
  12. Smith Medical
  13. Teleflex

Global Epidural Anesthetic Drugs and Device Market Overview


Highlights of The Epidural Anesthetic Drugs and Device Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Epidural Anesthetic Drugs
    2. Epidural Anesthetic Device
  1. By Application:

    1. Abdomen Procedures
    2. Pelvic Procedures
    3. Lower Extremity Procedures
    4. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Epidural Anesthetic Drugs and Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Epidural Anesthetic Drugs and Device Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Epidural anesthetic drugs and devices are medications or devices that are used to provide pain relief during surgery. They work by blocking nerve impulses from the brain, which reduces the amount of pain felt.

Some of the key players operating in the epidural anesthetic drugs and device market are Taj Pharmaceuticals Ltd, Pfizer, Fresenius Kabi, Areva Pharmaceuticals Inc., Farco Pharma GmbH, Mahendra Chemicals, Aurobindo Pharma Ltd, Amphastar Pharmaceuticals, Inc., B.Braun, BD, Meditech Devices, Smith Medical, Teleflex.

The epidural anesthetic drugs and device market is expected to grow at a compound annual growth rate of 5.8%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Epidural Anesthetic Drugs and Device Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Epidural Anesthetic Drugs and Device Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Epidural Anesthetic Drugs and Device Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Epidural Anesthetic Drugs and Device Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Epidural Anesthetic Drugs and Device Market Size & Forecast, 2018-2028       4.5.1 Epidural Anesthetic Drugs and Device Market Size and Y-o-Y Growth       4.5.2 Epidural Anesthetic Drugs and Device Market Absolute $ Opportunity

Chapter 5 Global Epidural Anesthetic Drugs and Device Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Epidural Anesthetic Drugs and Device Market Size Forecast by Type
      5.2.1 Epidural Anesthetic Drugs
      5.2.2 Epidural Anesthetic Device
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Epidural Anesthetic Drugs and Device Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Epidural Anesthetic Drugs and Device Market Size Forecast by Applications
      6.2.1 Abdomen Procedures
      6.2.2 Pelvic Procedures
      6.2.3 Lower Extremity Procedures
      6.2.4 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Epidural Anesthetic Drugs and Device Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Epidural Anesthetic Drugs and Device Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Epidural Anesthetic Drugs and Device Analysis and Forecast
   9.1 Introduction
   9.2 North America Epidural Anesthetic Drugs and Device Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Epidural Anesthetic Drugs and Device Market Size Forecast by Type
      9.6.1 Epidural Anesthetic Drugs
      9.6.2 Epidural Anesthetic Device
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Epidural Anesthetic Drugs and Device Market Size Forecast by Applications
      9.10.1 Abdomen Procedures
      9.10.2 Pelvic Procedures
      9.10.3 Lower Extremity Procedures
      9.10.4 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Epidural Anesthetic Drugs and Device Analysis and Forecast
   10.1 Introduction
   10.2 Europe Epidural Anesthetic Drugs and Device Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Epidural Anesthetic Drugs and Device Market Size Forecast by Type
      10.6.1 Epidural Anesthetic Drugs
      10.6.2 Epidural Anesthetic Device
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Epidural Anesthetic Drugs and Device Market Size Forecast by Applications
      10.10.1 Abdomen Procedures
      10.10.2 Pelvic Procedures
      10.10.3 Lower Extremity Procedures
      10.10.4 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Epidural Anesthetic Drugs and Device Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Epidural Anesthetic Drugs and Device Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Epidural Anesthetic Drugs and Device Market Size Forecast by Type
      11.6.1 Epidural Anesthetic Drugs
      11.6.2 Epidural Anesthetic Device
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Epidural Anesthetic Drugs and Device Market Size Forecast by Applications
      11.10.1 Abdomen Procedures
      11.10.2 Pelvic Procedures
      11.10.3 Lower Extremity Procedures
      11.10.4 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Epidural Anesthetic Drugs and Device Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Epidural Anesthetic Drugs and Device Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Epidural Anesthetic Drugs and Device Market Size Forecast by Type
      12.6.1 Epidural Anesthetic Drugs
      12.6.2 Epidural Anesthetic Device
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Epidural Anesthetic Drugs and Device Market Size Forecast by Applications
      12.10.1 Abdomen Procedures
      12.10.2 Pelvic Procedures
      12.10.3 Lower Extremity Procedures
      12.10.4 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Epidural Anesthetic Drugs and Device Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Epidural Anesthetic Drugs and Device Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Epidural Anesthetic Drugs and Device Market Size Forecast by Type
      13.6.1 Epidural Anesthetic Drugs
      13.6.2 Epidural Anesthetic Device
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Epidural Anesthetic Drugs and Device Market Size Forecast by Applications
      13.10.1 Abdomen Procedures
      13.10.2 Pelvic Procedures
      13.10.3 Lower Extremity Procedures
      13.10.4 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Epidural Anesthetic Drugs and Device Market: Competitive Dashboard
   14.2 Global Epidural Anesthetic Drugs and Device Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Taj Pharmaceuticals Ltd
      14.3.2 Pfizer
      14.3.3 Fresenius Kabi
      14.3.4 Areva Pharmaceuticals Inc.
      14.3.5 Farco Pharma GmbH
      14.3.6 Mahendra Chemicals
      14.3.7 Aurobindo Pharma Ltd
      14.3.8 Amphastar Pharmaceuticals, Inc.
      14.3.9 B.Braun
      14.3.10 BD
      14.3.11 Meditech Devices
      14.3.12 Smith Medical
      14.3.13 Teleflex

Our Trusted Clients

Contact Us